---
title: "INNOSTIC: Currently not engaged in the business of testing reagents related to Chikungunya fever symptoms"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260828745.md"
description: "On October 13th, INNOSTIC stated on the interactive platform that the company currently does not have a business related to testing reagents for symptoms of Chikungunya fever"
datetime: "2025-10-13T04:09:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260828745.md)
  - [en](https://longbridge.com/en/news/260828745.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260828745.md)
---

# INNOSTIC: Currently not engaged in the business of testing reagents related to Chikungunya fever symptoms

On October 13th, INNOSTIC stated on the interactive platform that the company currently does not have any business related to testing reagents for symptoms of Chikungunya fever

### Related Stocks

- [301584.CN](https://longbridge.com/en/quote/301584.CN.md)

## Related News & Research

- [Nio to showcase ES9 chassis capabilities via live broadcast ahead of Q1 earnings release](https://longbridge.com/en/news/287022748.md)
- [Fang Cheng Bao SUV delivery delays highlight BYD's manufacturing pressure amid tech transition](https://longbridge.com/en/news/286999045.md)
- [INSTANT VIEW-SpaceX files long awaited IPO, creating a fresh AI play](https://longbridge.com/en/news/287124128.md)
- [Why Is Oklo Stock Surging On Wednesday?](https://longbridge.com/en/news/287096677.md)
- [Micron's stock gets a boost. Are Samsung's problems helping?](https://longbridge.com/en/news/287092903.md)